TELO
Telomir Pharmaceuticals, Inc. Common Stock
There isn't enough reported data to score TELO yet.
TELO Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Under pressure | |
| Unavailable | |
| Unavailable |
TELO's profitability is currently under pressure. There isn't enough data to rate its revenue, cash flow and balance sheet.
TELO PE Valuation
TELO has no meaningful PE right now: it lost money over the past year.
TELO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| High |
Analysts expect TELO's losses to shrink, with revenue growing.
TELO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q1 2025 | -$0.40 | +$0.26 |
| Q4 2024 | -$0.56 | -$0.11 |
| Q3 2024 | -$0.80 | -$0.66 |
| Q2 2024 | -$0.66 | -$0.57 |
| Q1 2024 | -$0.66 | -$0.62 |
| Q4 2023 | -$0.45 | -$0.42 |
TELO lost $0.40 per share over the past year, a smaller loss than the year before.
TELO Quarterly Revenue
TELO's revenue is shrinking: $0 last quarter.
TELO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$586.4K | +$340.8K |
| Q2 2026 | -$1M | -$315.9K |
| Q1 2026 | -$1.8M | -$910.4K |
| Q4 2025 | -$1.2M | -$595.5K |
| Q3 2025 | -$927.3K | +$75.1K |
| Q2 2025 | -$696.4K | +$826.4K |
| Q1 2025 | -$863.1K | +$1.1M |
| Q4 2024 | -$605.8K | +$481.4K |
TELO has burned cash in almost every quarter: −$5M over the past year, against −$3M the year before.
TELO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +13% | +7.9M shares |
| 1 year | +112% | +36.4M shares |
| 3 years | +132% | +39.2M shares |
TELO has 69M diluted shares, up 112% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | — |
| Q1 2022 | — |
TELO Net Leverage
TELO's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
TELO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 21.0 | Oversold |
| Stochastic | 7.7 | Oversold |
TELO's weekly RSI is 21 (oversold) and its Stochastic is 8 (oversold).
TELO PE vs Healthcare Sector
TELO has no meaningful PE right now: it lost money over the past year.
TELO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.96 | 48% below |
| 20 week MA | $1.09 | 54% below |
| 50 week MA | $1.22 | 59% below |
| 100 week MA | $1.91 | 74% below |
TELO is in a downtrend: it's below all four of its weekly moving averages, and 74% below its 100-week average.
TELO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $5.00 | $4.87 | -2.6% |
| 2025 | $4.87 | $1.46 | -70% |
| 2026 YTD | $1.46 | $0.50 | -66% |
TELO has finished every year since 2024 lower, and it's down 66% so far in 2026.